Multiple myeloma outlook: Keeping the cobra in the basket
This article was originally published in Scrip
Executive Summary
Is multiple myeloma treatment at a tipping point? With new treatment approaches based on monoclonal antibodies and immuno-oncology drug combinations demonstrating improved outcomes, experts hope that the answer may be yes.